166 Followers on Owler

Overview Competitors Funding News & Insights

Accent Therapeutics Funding History

Since Accent Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Accent Therapeutics has raised $178.0M. Accent Therapeutics' last funding round was on Jan 2024 for a total of $75.0M.

Accent Therapeutics Funding Rounds

Series C

Jan 2024

$75M

11

Mirae Asset Capital Life Science, Mirae Asset Venture Investment, Bristol Myers Squibb, Johnson & Johnson Innovation, The Column Group, Atlas Venture, Droia Ventures, GV, EcoR1 Capital, The Mark Foundation for Cancer Research, Timefolio Capital

Series B

Apr 2020

$63M

7

EcoR1 Capital, GV, The Mark Foundation for Cancer Research, NS Investment, Droia Ventures, Atlas Venture, The Column Group

Series A

May 2018

$40M

3

The Column Group, Atlas Venture, EcoR1 Capital

Accent Therapeutics Investors

Mirae Asset Capital Life Science

Series C

Jan 2024

Mirae Asset Venture Investment

Series C

Jan 2024

Bristol Myers Squibb

Series C

Jan 2024

Johnson & Johnson Innovation

Series C

Jan 2024

The Column Group

Series C, Series B, Series A

Jan 2024, Apr 2020, May 2018

Accent Therapeutics has 12 investors, including Mirae Asset Capital Life Science, Mirae Asset Venture Investment and Bristol Myers Squibb. The latest investment occurred in Jan 2024.